Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jessica Castrillon Lal"'
Publikováno v:
American Journal of Medicine Open, Vol 10, Iss , Pp 100042- (2023)
Objective: Obesity affects 14.7 million children and adolescents in the United States. Children's health behaviors are affected by parental health practices. Therefore, pediatric obesity interventions should include parents. The objective of this stu
Externí odkaz:
https://doaj.org/article/ccfef0f2d251427698945afcbcbdd725
Autor:
Sherry-Ann Brown, Rodney Sparapani, Kristen Osinski, Jun Zhang, Jeffrey Blessing, Feixiong Cheng, Abdulaziz Hamid, Mehri Bagheri MohamadiPour, Jessica Castrillon Lal, Anai N. Kothari, Pedro Caraballo, Peter Noseworthy, Roger H. Johnson, Kathryn Hansen, Louise Y. Sun, Bradley Crotty, Yee Chung Cheng, Gift Echefu, Krishna Doshi, Jessica Olson
Publikováno v:
American Heart Journal Plus, Vol 32, Iss , Pp 100306- (2023)
Interdisciplinary research teams can be extremely beneficial when addressing difficult clinical problems. The incorporation of conceptual and methodological strategies from a variety of research disciplines and health professions yields transformativ
Externí odkaz:
https://doaj.org/article/210eeffc0f48419c8be57ee588ef4c77
Autor:
Jessica Castrillon Lal, Madeline G. Townsend, Anita K. Mehta, Madisson Oliwa, Eric Miller, Alaba Sotayo, Emily Cheney, Elizabeth A. Mittendorf, Anthony Letai, Jennifer L. Guerriero
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-24 (2021)
Abstract Background The heterogeneity of the breast tumor microenvironment (TME) may contribute to the lack of durable responses to immune checkpoint blockade (ICB); however, mouse models to test this are currently lacking. Proper selection and use o
Externí odkaz:
https://doaj.org/article/f6e80e8609494d5fa20f224fe558ca53
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract Background Modern therapies in oncology have increased cancer survivorship, as well as the incidence of cardiovascular adverse events. While immune checkpoint inhibitors have shown significant clinical impact in several cancer types, the inc
Externí odkaz:
https://doaj.org/article/8eaaa99a0ee24474b6cb483d77799f4a
Autor:
Jessica Castrillon Lal
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-2 (2022)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers, with less than 10% of patients surviving more than five years. A major challenge of PDAC is understanding the complexity of the tumor architecture and identifying targetab
Externí odkaz:
https://doaj.org/article/98048d1a3d9645e5b2a45179ee13b97c
Autor:
Sherry-Ann Brown, Rodney Sparapani, Kristen Osinski, Jun Zhang, Jeffrey Blessing, Feixiong Cheng, Abdulaziz Hamid, Generika Berman, Kyla Lee, Mehri BagheriMohamadiPour, Jessica Castrillon Lal, Anai N. Kothari, Pedro Caraballo, Peter Noseworthy, Roger H. Johnson, Kathryn Hansen, Louise Y. Sun, Bradley Crotty, Yee Chung Cheng, Jessica Olson
Publikováno v:
American Heart Journal Plus, Vol 13, Iss , Pp 100094- (2022)
Study objective: A multi-institutional interdisciplinary team was created to develop a research group focused on leveraging artificial intelligence and informatics for cardio-oncology patients. Cardio-oncology is an emerging medical field dedicated t
Externí odkaz:
https://doaj.org/article/23aaf375d1e947bc830a313861b4815b
Autor:
Jessica Castrillon Lal, Feixiong Cheng
Publikováno v:
Machine Learning and Deep Learning in Computational Toxicology ISBN: 9783031207297
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cb1704e684b6663829152f0dacc4e4e
https://doi.org/10.1007/978-3-031-20730-3_24
https://doi.org/10.1007/978-3-031-20730-3_24
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-10 (2021)
Cardio-oncology
Cardio-oncology
Background Modern therapies in oncology have increased cancer survivorship, as well as the incidence of cardiovascular adverse events. While immune checkpoint inhibitors have shown significant clinical impact in several cancer types, the incidence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff81fe0a5626a0bf8ef83514a853030
https://doaj.org/article/8eaaa99a0ee24474b6cb483d77799f4a
https://doaj.org/article/8eaaa99a0ee24474b6cb483d77799f4a
Autor:
Feixiong Cheng, Julie H. Rennison, Mina K. Chung, John Barnard, Yadi Zhou, Shamone R. Gore-Panter, Jessica Castrillon Lal, David R. Van Wagoner
Atrial fibrillation (AF) is a significant cause of morbidity and mortality, and effective therapeutic interventions are lacking. Here, we harness an integrative, network medicine approach to repurpose FDA-approved drugs for AF. We hypothesize that th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffcf7823c381b6dc52a8fcfc9d6bd355
https://doi.org/10.1101/2021.09.17.460826
https://doi.org/10.1101/2021.09.17.460826
Autor:
Emily M. Cheney, Jessica Castrillon Lal, Alaba Sotayo, Elizabeth A. Mittendorf, Anthony Letai, Madeline G Townsend, Madisson Oliwa, Jennifer L. Guerriero, Eric M. Miller, Anita K. Mehta
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 23, Iss 1, Pp 1-24 (2021)
Breast Cancer Research, Vol 23, Iss 1, Pp 1-24 (2021)
BackgroundThe heterogeneity of the breast tumor microenvironment (TME) may contribute to the lack of durable responses to immune checkpoint blockade (ICB); however, mouse models to test this are currently lacking. Proper selection and use of preclini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4ef6954fbba8c7c545a17d9d4ccf31
https://pubmed.ncbi.nlm.nih.gov/34353349
https://pubmed.ncbi.nlm.nih.gov/34353349